Modified Xylanase C-Terminal Deletion for Thermal Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing xylanases have limitations in activity and stability, particularly when the cellulose-binding domain is removed, which can lead to reduced enzyme activity.

Innovation Solution

A modified xylanase is developed by deleting the cellulose-binding module 1 (CBM1) of the xylanase produced by Talaromyces cellulolyticus CF-2612 strain, resulting in a polypeptide with enhanced enzyme activity and stability at higher temperatures and various pH levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the cellulose-binding domain (CBM1) is removed from xylanase, then the enzyme activity is significantly increased, but the enzyme may lose stability and binding capability

Engineering Contradiction:
Improveenzyme activityVSAvoidenzyme stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent removes the cellulose-binding domain (CBM1) from the xylanase enzyme structure. This extraction of a specific functional module results in increased enzymatic activity while maintaining stability through the remaining structural components, resolving the contradiction between activity enhancement and stability preservation

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent modifies the enzyme's structural parameters by deleting specific amino acid residues (12-73 amino acid residues) corresponding to the CBM1 domain. This parameter change in the protein sequence leads to altered enzymatic properties, achieving higher activity while maintaining thermal and pH stability

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the cellulose-binding domain is removed from xylanase, then the enzyme activity is increased, but the enzyme may become less effective in biomass processing

Engineering Contradiction:
Improveenzyme activityVSAvoideffectiveness in biomass processing
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The cellulose-binding domain is extracted from the enzyme, and the patent demonstrates that the remaining enzyme structure retains sufficient functionality for biomass processing applications, achieving both activity enhancement and process effectiveness

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of adding binding domains to enhance effectiveness, the patent inverts the approach by removing the binding domain to achieve higher activity, relying on the catalytic domain's inherent capabilities to process biomass effectively

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified xylanase exhibits 1.3 to 1.9 times higher enzyme activity compared to wild-type xylanase at 45°C and maintains stability at 70°C, with improved thermal and pH stability, making it more effective in biomass processing.

Implementation Method 1

Xylanase is a generic term for a group of enzymes that hydrolyze xylan

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

xylanase is used in the enzymatic degradation of agricultural waste for alcohol fuels, enzymatic treatment for liberating saccharides in animal feed

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS10100295B2Modified xylanase
Publication Date: 2018.10.16 NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE & TECHNOLOGY
  • US10100295B2 patent drawing
  • US10100295B2 patent drawing

AI summary

Provided is a modified xylanase. The polypeptide has xylanase activity and has an amino acid sequence with deletion of at least 12 consecutive amino acid residues at the C-terminus of the amino acid sequence of SEQ ID NO: 1 or an amino acid sequence having at least 90% identity with the amino acid sequence of SEQ ID NO: 1.